2012 annual financial data
Eloxx Pharmaceuticals 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was -2,193.02%.
Operating income was -5,090,391 USD and net income was -5,066,133 USD.
Operating cash flow was -4,386,049 USD.
Get free Eloxx Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 200,000 USD
- Operating income
- -5,090,391 USD
- Net income
- -5,066,133 USD
- Operating cash flow
- -4,386,049 USD